BuqitongluO Granule for Qi Deficiency and Blood Stasis Syndrome
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 432 participants.
Also called NCT04408261
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 432 participants
- Sponsor
- Registry
-
NCT04408261
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT04408261. Randomized; quadruple masking; primary purpose treatment. Start 2020-07-22 (actual); primary completion 2022-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- BuqitongluO Granule for Qi Deficiency and Blood Stasis Syndrome
- Acronym
- BOSS
- Condition
- Stroke, Ischemic
- Condition
- Coronary Artery Disease
- Condition
- Angina Pectoris, Stable
- Condition
- Diabetic Peripheral Neuropathy
- Intervention (Drug)
- Buqitongluo Granule
- Intervention (Drug)
- Buqitongluo Granule Placebo
- Intervention (Other)
- Standard care
- Lead sponsor
- Dongzhimen Hospital, Beijing
- Collaborator
- Affiliated Hospital of Changchun University of Chinese Medicine
- Collaborator
- Affiliated Hospital of Shandong University of Traditional Chinese Medicine
- Collaborator
- Chengdu University of Traditional Chinese Medicine
- Collaborator
- The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
- Collaborator
- First Affiliated Hospital of Heilongjiang Chinese Medicine University
- Collaborator
- Second Affiliated Hospital of Heilongjiang University of Chinese Medicine
- Collaborator
- The Second Affiliated Hospital of Hunan University of Traditional Chinese Medicine
- Collaborator
- Hunan Academy of Traditional Chinese Medicine Affiliated Hospital
- Collaborator
- The First Clinical Hospital of Jilin Academy of Traditional Chinese Medicine
- Collaborator
- Shaanxi Buchang Pharmaceutical Co., Ltd
- Collaborator
- Beijing Chuanglikechuang Medical Technology Development Co., Ltd.
- Collaborator
- Shanghai Youningwei Biotechnology Co., Ltd.
- Collaborator
- Wuhan Zhizhi Medical Technology Co., Ltd.
- Collaborator
- Wuhan Third Hospital
- Collaborator
- Rizhao Hospital of Traditional Chinese Medicine
- Collaborator
- First Affiliated Hospital of Guangxi Medical University
- Collaborator
- People's Hospital of Guangxi Zhuang Autonomous Region
Record details
- Record id
cardio:ct-nct04408261- Content hash
977812b38cc9af236b4f881813a150c7c9d4285c8983232ecdbdd0eba5a4ca5b